Formats
  1. Journal Article (66746)
  2. Meeting Abstract (33620)
  3. Book Section (5027)
  4. Review (3744)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (660)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39033)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22056)
  4. Surgery (21247)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15762)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1050)

More People

Years
  1. 2025 (1982)
  2. 2024 (5377)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5598)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115370)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Surgery for medullary thyroid cancer
    Book Section

    Gréant, E.; Shaha, A. R.; Nixon, I. J.
    In Mallick, U. K.; Harmer, C. (Eds.) Practical Management of Thyroid Cancer: A Multidisciplinary Approach. 3rd ed (2023)

    Fulltext@MSK | Save
  • Interventional diagnostic and therapeutic procedures in surgical oncology
    Book Section

    Barnett, K. M.; Brennan, V.; Shah, S. H.; Rieth, E. F.; Kollmeier, M. A.
    In Huang, J.; Huang, J.; Liu, H. (Eds.) Anesthesia for Oncological Surgery (2023)

    Fulltext@MSK | Save
  • Honing in on the hospital-at-home model
    Editorial

    Mullangi, S.; Daly, B.
    Mayo Clinic Proceedings: Digital Health (2023)

    Fulltext@MSK | Save
  • ROCK1 orchestrates B-cell differentiation under stress
    Meeting Abstract

    Rivera-Correa, J.; Gupta, S.; Ricker, E.; Flores-Castro, D.; Jenkins, D.; Vulcano, S.; Pannellini, T.; Miele, M.; Li, Z.; Zamponi, N.; more...
    Arthritis & Rheumatology (2023)

    Fulltext@MSK | Save
  • Lower limb lesions
    Book Section

    Forsea, A. M.; Oliveira, A.; Donoso, F.; Peirano, D.; Navarrete Dechent, C.; Uribe, P.; Camela, E.; Liopyris, K.; Álvarez, M. R.; Dueñas, A. R.; more...
    In Cabo, H.; Lallas, A. (Eds.) Dermatoscopic Atlas of Non-Pigmented Lesions: Case-based Analysis and Management Options (2023)

    Fulltext@MSK | Save
  • ENGOT-EN20/GOG-3083/XPORT-EC-042 a phase 3, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy for patients with P53 wild-type, advanced or recurrent endometrial carcinoma
    Meeting Abstract

    Vergote, I.; Mirza, M. R.; Coleman, R.; Fidalgo, J. P.; Monk, B.; Valabrega, G.; Slomovitz, B.; Van Gorp, T.; Moore, K.; Sehouli, J.; more...
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • Surgical approach to cervical cancer and considerations for nerve sparing radical hysterectomy
    Meeting Abstract

    Praiss, A.; Leitao, M.; Kim, S.; Zammarrelli, B.; Abu-Rustum, N.; Sonoda, Y.
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • Phase 1/2 study of galinpepimut-S plus pembrolizumab combination in patients with WT1+platinum-resistant ovarian cancer in 2nd/3rd line of therapy
    Meeting Abstract

    Ocearbhaill, R.; Holmes, J.; Bastos, B.; Fu, S. Q.; Muenzen, R.; Cohen, J.; Cicic, D.; Ali, S.
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • A phase 2, open-label, single-arm, prospective, multi-center study of nab-sirolimus plus letrozole in advanced or recurrent endometrioid endometrial cancer
    Meeting Abstract

    Dockery, L.; Priebe, A.; Duska, L.; Green, A.; Mathews, C.; Musa, F.; O'Malley, D.; Puechl, A.; Ding, L.; Schmid, A.; more...
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • First-in-human phase 1/2 study of ubamatamab, a MUC16XCD3 bispecific antibody, administered alone or in combination with cemiplimab in patients with recurrent ovarian cancer
    Meeting Abstract

    Moore, K.; Bouberhan, S.; Hamilton, E.; Liu, J. Y.; O'Cearbhaill, R.; O'Malley, D.; Papadimitriou, K.; Schröder, D.; Van Nieuwenhuysen, E.; Yoo, S. Y.; more...
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save